The ADDF has provided a list of resources to support the work of ADDF awardees and other funded scientists.

Reporting


Institutions that receive funding from the ADDF are required to submit interim and final scientific and financial progress reports to discuss their findings, methods, and, when appropriate, future directions. Follow-on funding can be discussed during this process. A new letter of intent must be submitted for follow-on funding proposals.

All awardees are required to notify the ADDF of any changes made to the budget. A no cost extension (NCE) may be allowed but must be approved by the ADDF in advance. To request an NCE, please email grants@alzdiscovery.org, describing the reason for the request.

 

To Submit

Please use only these forms to submit both interim and final scientific and financial reports. Completed reports should be submitted to grants@alzdiscovery.org.

Academic-Industry Partnerships


Apply to programs that provide industry expertise and resources.

ADDF Partners

Harrington Discovery Institute
Pfizer's Centers for Therapeutic Innovation

Other Programs

AstraZeneca's Open Innovation
GSK Discovery Partnerships with Academia
Lilly's Open Innovation Drug Discovery

Online Tools


ADDF ACCESS: CRO Finder

Search for contract research organization (CROs) specializing in CNS diseases, and find best practice guidelines, publications, and webinars on CNS drug discovery CRO selection and management.

Academic Drug Discovery Consortium

Search for university-led drug discovery centers and training material.

Scientific Publications


Read scientific and opinion papers written by ADDF staff scientists.

Print